PERSPECTA

News from every angle

Back to headlines

Appeals Court Revives Tylenol Autism Lawsuits

A U.S. appeals court has revived private lawsuits linking the painkiller Tylenol to autism and ADHD, overturning a previous ruling that had dismissed the cases. This decision allows plaintiffs to proceed with claims against Kenvue, the manufacturer.

13 Jul, 16:22 — 13 Jul, 22:42
PostShare

The Story

Analyzing sources…

Source Diversity

Source Diversity

Excellent (75/100)
6 sources33/33
Spectrum spread5/5 buckets covered33/33
Far L2
Far Left (2)
The IndependentNYT
Left1
Left (1)
cnbc
Center1
Center (1)
FT
Right1
Right (1)
seeking-alpha
Far R1
Far Right (1)
zerohedge
Geographic diversity2 regions9/34
US4UK2

Sources

Showing 6 of 6 sources
NYTMostly Factual13d ago

Appeals Court Revives Lawsuits Tying Tylenol Use in Pregnancy to Autism and A.D.H.D.

A federal appeals court overruled a district court judge who dismissed the lawsuits, citing unreliable scientific evidence.

By Azeen Ghorayshi

Read full article →
FTVery High13d ago

US appeals court revives lawsuits linking painkiller Tylenol to autism

Federal panel in New York finds trial judge wrongly excluded expert testimony in dismissing litigation

Read full article →
cnbcMostly Factual13d ago

U.S. appeals court revives private lawsuits linking Tylenol to autism

There is no firm scientific evidence linking Tylenol use during pregnancy to autism and attention ⁠deficit hyperactivity ‌disorder in children.

Read full article →
The IndependentMostly Factual12d ago

Judges allow lawsuit that ties Tylenol to autism to continue after it was dismissed for lack of ‘scientific evidence’

The move has revived more than 500 private lawsuits against Tylenol maker Kenvue

By Rhian Lubin

Read full article →
seeking-alphaMixed12d ago

Teva lawsuit over generics of Lilly's Forteo brought back by appeals court

Read full article →
zerohedgeLow13d ago

Appeals Court Revives Tylenol Autism Lawsuits Against Kenvue

Appeals Court Revives Tylenol Autism Lawsuits Against Kenvue A federal appeals court has breathed new life into litigation accusing Kenvue of failing to disclose alleged risks tied to taking Tylenol during pregnancy, reversing an earlier ruling that had effectively stopped hundreds of cases, according to a new report from Bloomberg. On Monday, the 2nd U.S. Circuit Court of Appeals concluded that the trial judge went too far in throwing out testimony from three expert witnesses. ...

By Tyler Durden

Read full article →